
  
    
      
        Introduction_NNP
        Hypokalemia_NNP and_CC many_JJ types_NNS of_IN electrocardiographic_JJ (_( ECG_NNP )_)
        abnormality_NN are_VBP observed_VBN during_IN the_DT acute_JJ phase_NN of_IN
        subarachnoid_NN hemorrhage_NN (_( SAH_NNP )_) [_NN 1_CD 2_CD 3_CD ]_NN ._. Among_IN ECG_NNP
        abnormalities_NNS ,_, a_DT prolongation_NN of_IN the_DT QT_NNP interval_NN ,_,
        especially_RB when_WRB associated_VBN with_IN hypokalemia_NN ,_, deserves_VBZ
        particular_JJ attention_NN because_IN it_PRP is_VBZ frequently_RB observed_VBN in_IN
        those_DT patients_NNS who_WP develop_VBP life-threatening_JJ ventricular_NN
        arrhythmias_NNS such_JJ as_IN tor-sades_JJ de_IN pointes_NNS [_NN 1_CD 2_CD 4_CD ]_NN ._.
        However_RB ,_, the_DT pathogeneses_NNS of_IN these_DT abnormalities_NNS during_IN the_DT
        acute_JJ phase_NN of_IN SAH_NNP have_VBP not_RB yet_RB been_VBN fully_RB
        investigated_VBN ._.
        It_PRP is_VBZ commonly_RB believed_VBN that_DT hypokalemia_NN identified_VBN
        during_IN the_DT acute_JJ phase_NN of_IN SAH_NNP is_VBZ caused_VBN by_IN a_DT catecholamine_NN
        surge_NN following_VBG SAH_NNP [_NN 2_CD ]_NN ._. In_IN healthy_JJ male_JJ volunteers_NNS ,_,
        Brown_NNP and_CC coworkers_NNS [_NN 5_CD ]_NN demonstrated_VBN that_DT serum_NN infused_VBN
        adrenaline_NN (_( epinephrine_NN )_) caused_VBN excessive_JJ activation_NN of_IN the_DT
        sodium_NN /_NN potassium-_NN ATPase_NNP (_( Na_NNP +_NN /_NN K_NNP +_NN -_: ATPase_NNP ;_: Na_NNP +_NN /_NN K_NNP +_NN pump_NN )_) as_IN
        a_DT result_NN of_IN β_NN 
        2_CD -_: adrenergic_JJ receptor_NN stimulation_NN ;_: this_DT
        resulted_VBD in_IN trafficking_NN of_IN potassium_NN ions_NNS from_IN
        extracellular_NN to_TO intracellu-lar_JJ spaces_NNS ,_, leading_VBG to_TO a_DT
        decrease_NN in_IN serum_NN potassium_NN levels_NNS ._.
        Recent_JJ work_NN showed_VBD that_IN there_EX were_VBD some_DT relationships_NNS
        between_IN serum_NN catecholamine_NN levels_NNS and_CC QT_NNP intervals_NNS during_IN
        the_DT acute_JJ phase_NN of_IN SAH_NNP [_NN 1_CD 6_CD ]_NN ._. However_RB ,_, one_CD cannot_NN refute_VB
        the_DT possibility_NN that_IN the_DT catecholamine_NN surge_NN may_MD influence_VB
        the_DT QT_NNP interval_NN indirectly_RB via_IN hypokalemia_NN ,_, because_IN
        hypokalemia_NN (_( as_RB well_RB as_IN hypocalcemia_NN and_CC hypomagnesemia_NN )_)
        can_MD cause_VB a_DT prolongation_NN in_IN the_DT QT_NNP interval_NN [_NN 4_CD 7_CD 8_CD 9_CD ]_NN
        ._.
        In_IN a_DT previous_JJ preliminary_JJ study_NN [_NN 3_CD ]_NN ,_, we_PRP suggested_VBD
        that_IN women_NNS may_MD be_VB more_RBR prone_JJ than_IN men_NNS to_TO develop_VB both_DT
        hypokalemia_NN and_CC prolongation_NN in_IN the_DT corrected_VBN QT_NNP (_( QTc_NNP )_)
        interval_NN on_IN the_DT first_JJ day_NN of_IN SAH_NNP ._. In_IN the_DT present_JJ
        prospective_JJ study_NN ,_, we_PRP assessed_VBD various_JJ possible_JJ risk_NN
        factors_NNS for_IN the_DT QTc_NNP prolongation_NN that_WDT is_VBZ observed_VBN in_IN SAH_NNP
        patients_NNS in_IN order_NN to_TO examine_VB independent_JJ risk_NN factors_NNS by_IN
        means_NNS of_IN multivariate_NN analysis_NN ._.
      
      
        Patients_NNS and_CC method_NN
        
          Patients_NNS
          We_PRP prospectively_RB studied_VBD 100_CD patients_NNS admitted_VBN within_IN
          24_CD hours_NNS after_IN onset_NN of_IN SAH_NNP to_TO the_DT National_NNP Defense_NNP
          Medical_NNP College_NNP Hospital_NNP between_IN January_NNP 1997_CD and_CC April_NNP
          2002_CD ._. Of_IN these_DT 100_CD patients_NNS ,_, 36_CD were_VBD men_NNS and_CC 64_CD were_VBD
          women_NNS ;_: mean_VB age_NN on_IN admission_NN was_VBD 59_CD ._. 1_LS ±_NN 11_CD ._. 8_CD years_NNS ,_, with_IN
          a_DT range_NN of_IN 21_CD -_: 82_CD years_NNS ._. Neurologic_NNP condition_NN on_IN admission_NN
          was_VBD evaluated_VBN according_VBG to_TO the_DT Hunt_NNP and_CC Kosnik_NNP
          classification_NN [_NN 10_CD ]_NN ,_, and_CC severity_NN of_IN SAH_NNP was_VBD assessed_VBN
          according_VBG to_TO Fisher_NNP 's_POS classification_NN [_NN 11_CD ]_NN ._. The_DT
          exclusion_NN criteria_NNS included_VBD endocrino-logic_JJ disease_NN ,_,
          heart_NN disease_NN ,_, renal_JJ failure_NN ,_, previous_JJ SAH_NNP or_CC
          intracerebral_NN hemorrhage_NN ,_, young_JJ age_NN (_( <_NN 19_CD years_NNS )_) ,_,
          pregnancy_NN ,_, pacemaker_NN rhythm_NN ,_, or_CC taking_VBG any_DT of_IN the_DT
          following_JJ drugs_NNS :_: digitalis_NNS ,_, quinidine_NN ,_, procainamide_NN ,_,
          disopyramide_NN ,_, and_CC diuretics_NNS ._. All_DT patients_NNS had_VBD brain_NN
          computed_JJ tomography_NN studies_NNS compatible_JJ with_IN their_PRP$
          diagnoses_NNS ._. Each_DT patient_NN underwent_VBD a_DT cerebral_JJ angiogram_NN to_TO
          identify_VB a_DT ruptured_VBN aneurysm_NN ,_, except_IN for_IN eight_CD patients_NNS
          whose_WP$ SAH_NNP were_VBD so_RB severe_JJ that_IN there_EX was_VBD no_DT indication_NN for_IN
          cerebral_JJ angiography_NN ._. Patients_NNS with_IN traumatic_JJ SAH_NNP or_CC SAH_NNP
          of_IN unknown_JJ origin_NN ,_, despite_IN assessment_NN by_IN cerebral_JJ
          angiography_NN ,_, were_VBD also_RB excluded_VBN from_IN the_DT study_NN ._. Informed_NNP
          consent_NN was_VBD obtained_VBN from_IN the_DT patients_NNS and_CC /_NN or_CC their_PRP$
          guardians_NNS ._.
        
        
          Data_NNP collection_NN
          Standard_NNP 12_CD -_: lead_VB ECG_NNP was_VBD performed_VBN immediately_RB after_IN
          admission_NN ._. Two_CD consecutive_JJ QT_NNP intervals_NNS were_VBD manually_RB
          measured_VBN for_IN all_DT 12_CD leads_NNS of_IN the_DT ECG_NNP with_IN the_DT assessor_NN
          blinded_JJ to_TO the_DT name_NN and_CC group_NN of_IN the_DT patient_NN ._. The_DT QT_NNP
          intervals_NNS were_VBD measured_VBN from_IN the_DT beginning_NN of_IN the_DT QRS_NNP
          complex_JJ to_TO the_DT visual_JJ return_NN of_IN the_DT T_NN wave_NN to_TO the_DT
          isoelectric_JJ line_NN ,_, and_CC were_VBD corrected_VBN for_IN heart_NN rate_NN using_VBG
          the_DT Bazett_NNP formula_NN :_: QTc_NNP =_SYM QT_NNP /_NN (_( square_JJ root_NN of_IN RR_NNP
          interval_NN )_) ._. The_DT mean_NN QTc_NNP interval_NN was_VBD calculated_VBN from_IN all_DT
          QTc_NNP intervals_NNS measured_VBN ._. The_DT intraob-server_JJ coefficient_NN of_IN
          variation_NN was_VBD 1_CD ._. 5_CD %_NN and_CC the_DT interobserver_NN coefficient_NN of_IN
          variation_NN was_VBD 1_CD ._. 8_CD %_NN ._. Blood_NNP samples_NNS were_VBD obtained_VBN from_IN the_DT
          patients_NNS at_IN the_DT same_JJ time_NN as_IN ECG_NNP ,_, and_CC serum_NN levels_NNS of_IN
          sodium_NN ,_, potassium_NN ,_, calcium_NN ,_, adrenaline_NN ,_, noradrenaline_NN
          (_( norepinephrine_NN )_) ,_, dopamine_NN ,_, antidiuretic_JJ hormone_NN ,_, and_CC
          glucose_NN were_VBD measured_VBN ._.
        
        
          Statistical_NNP analyses_NNS
          In_IN order_NN to_TO identify_VB potential_JJ risk_NN factors_NNS for_IN severe_JJ
          QTc_NNP prolongation_NN ,_, univariate_NN analysis_NN was_VBD conducted_VBN using_VBG
          the_DT χ_NN 2_CD test_NN ,_, Student_NNP 's_POS 
          t_NN test_NN ,_, or_CC Mann-_NNP Whitney_NNP U_NNP test_NN ._. The_DT
          model_NN was_VBD reduced_VBN using_VBG manual_JJ back_RB and_CC forth_RB procedure_NN ,_,
          with_IN variable_JJ selection_NN based_VBN on_IN the_DT statistical_JJ
          significance_NN of_IN the_DT estimates_NNS (_( 
          P_NN <_NN 0_CD ._. 1_LS )_) ._. Multiple_NNP logistic_JJ
          regression_NN analysis_NN was_VBD then_RB performed_VBN to_TO identify_VB
          independent_JJ risk_NN factors_NNS for_IN severe_JJ QTc_NNP prolongation_NN ._.
          Pearson_NNP 's_POS correlation_NN coefficient_NN was_VBD used_VBN to_TO assess_VB the_DT
          correlation_NN between_IN serum_NN potassium_NN levels_NNS and_CC QTc_NNP
          intervals_NNS ._. Data_NNP are_VBP expressed_VBN as_IN means_VBZ ±_NN SD_NNP ._. 
          P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ and_CC all_DT analyses_NNS were_VBD performed_VBN
          using_VBG the_DT StatView_NNP Version_NNP 5_CD ._. 0_CD statistical_JJ package_NN (_( SAS_NNP
          Institute_NNP Inc_NNP ,_, Cary_NNP ,_, NC_NNP ,_, USA_NNP )_) ._.
        
      
      
        Results_NNS
        
          Univariate_NNP analysis_NN
          Univariate_NNP analyses_NNS demonstrated_VBN that_IN there_EX were_VBD
          significant_JJ relationships_NNS between_IN the_DT category_NN of_IN QTc_NNP
          interval_NN and_CC patient_NN sex_NN (_( Table_NNP 1_LS )_) ._. Significant_JJ
          relationships_NNS were_VBD also_RB identified_VBN between_IN category_NN of_IN
          QTc_NNP interval_NN and_CC the_DT serum_NN concentrations_NNS of_IN potassium_NN ,_,
          calcium_NN ,_, or_CC glucose_NN (_( Table_NNP 1_LS )_) ._. Severe_NNP QTc_NNP prolongation_NN
          (_( 470_CD ms_NNS or_CC more_JJR ;_: 
          n_NN =_SYM 40_CD )_) was_VBD more_RBR frequent_JJ among_IN
          female_JJ SAH_NNP patients_NNS (_( 53_CD ._. 1_LS %_NN ;_: 
          P_NN =_SYM 0_CD ._. 0004_CD )_) than_IN among_IN male_JJ
          patients_NNS (_( 16_CD ._. 7_CD %_NN )_) ._. The_DT patients_NNS with_IN severe_JJ QTc_NNP
          prolongation_NN had_VBD lower_JJR serum_NN potassium_NN levels_NNS (_( 3_CD ._. 21_CD ±_NN
          0_CD ._. 43_CD mmol_NN /_NN l_NN ;_: 
          P_NN <_NN 0_CD ._. 0001_CD )_) than_IN did_VBD patients_NNS
          with_IN a_DT QTc_NNP interval_NN of_IN less_JJR than_IN 470_CD ms_NNS (_( 3_CD ._. 63_CD ±_NN 0_CD ._. 42_CD
          mmol_NN /_NN l_NN )_) ._. Hypokalemia_NNP was_VBD defined_VBN as_IN serum_NN potassium_NN level_NN
          below_IN 3_CD ._. 5_CD mmol_NN /_NN l_NN ._. Severe_NNP QTc_NNP prolongation_NN was_VBD more_RBR
          frequently_RB found_VBD among_IN SAH_NNP patients_NNS with_IN hypokalemia_NN
          (_( 58_CD ._. 8_CD %_NN ;_: 
          P_NN <_NN 0_CD ._. 0001_CD )_) than_IN among_IN SAH_NNP
          patients_NNS with_IN normokalemia_NN (_( 20_CD ._. 4_LS %_NN )_) ._. Patients_NNS with_IN severe_JJ
          QTc_NNP prolongation_NN also_RB had_VBD lower_JJR serum_NN calcium_NN levels_NNS
          (_( 8_CD ._. 29_CD ±_NN 0_CD ._. 52_CD mmol_NN /_NN l_NN ;_: 
          P_NN <_NN 0_CD ._. 1_LS )_) as_IN compared_VBN with_IN
          patients_NNS with_IN a_DT QTc_NNP interval_NN of_IN less_JJR than_IN 470_CD ms_NNS (_( 8_CD ._. 52_CD ±_NN
          0_CD ._. 39_CD mmol_NN /_NN l_NN )_) ._. The_DT concentration_NN of_IN serum_NN glucose_NN was_VBD
          significantly_RB higher_JJR in_IN patients_NNS with_IN a_DT severely_RB
          prolonged_JJ QTc_NNP interval_NN (_( 207_CD ±_NN 56_CD mg_NN /_NN dl_NN ;_: 
          P_NN <_NN 0_CD ._. 02_CD )_) as_IN compared_VBN with_IN
          patients_NNS with_IN a_DT QTc_NNP interval_NN of_IN less_JJR than_IN 470_CD ms_NNS (_( 178_CD ±_NN
          49_CD mg_NN /_NN dl_NN )_) ._.
          There_EX was_VBD ,_, however_RB ,_, no_DT relation_NN between_IN category_NN of_IN
          QTc_NNP interval_NN and_CC patient_NN age_NN ,_, Hunt_NNP and_CC Kosnik_NNP grade_NN ,_,
          Fisher_NNP 's_POS classification_NN for_IN computed_JJ tomography_NN ,_, site_NN of_IN
          ruptured_JJ aneurysm_NN ,_, or_CC the_DT serum_NN concentration_NN of_IN sodium_NN ,_,
          adrenaline_NN ,_, noradrenaline_NN ,_, dopamine_NN ,_, or_CC antidiuretic_JJ
          hormone_NN ._. There_EX were_VBD significant_JJ inverse_NN correlations_NNS
          between_IN serum_NN potassium_NN level_NN and_CC serum_NN concentrations_NNS of_IN
          adrenaline_NN ,_, noradrenaline_NN ,_, dopamine_NN ,_, and_CC antidiuretic_JJ
          hormone_NN (_( 
          r_LS =_SYM -_: 0_CD ._. 712_CD ,_, -_: 0_CD ._. 573_CD ,_, -_: 0_CD ._. 432_CD ,_, -_: 0_CD ._. 442_CD ,_,
          respectively_RB )_) ._. Furthermore_RB ,_, female_JJ SAH_NNP patients_NNS had_VBD lower_JJR
          potassium_NN levels_NNS (_( 3_CD ._. 36_CD ±_NN 0_CD ._. 50_CD mmol_NN /_NN l_NN ;_: 
          P_NN =_SYM 0_CD ._. 001_CD )_) than_IN did_VBD male_JJ SAH_NNP
          patients_NNS (_( 3_CD ._. 65_CD ±_NN 0_CD ._. 36_CD mmol_NN /_NN l_NN )_) ._.
        
        
          Multivariate_NNP analysis_NN
          The_DT multivariate_NN analyses_NNS showed_VBD that_IN female_JJ sex_NN and_CC
          hypokalemia_NN were_VBD independent_JJ risk_NN factors_NNS for_IN severe_JJ QTc_NNP
          prolongation_NN in_IN patients_NNS with_IN SAH_NNP ._. In_IN the_DT first_JJ analysis_NN ,_,
          the_DT serum_NN potassium_NN level_NN was_VBD considered_VBN a_DT continuous_JJ
          variable_JJ (_( analysis_NN 1_CD ,_, Table_NNP 2_LS )_) ._. An_DT increase_NN of_IN 1_CD mmol_NN /_NN l_NN
          in_IN serum_NN potassium_NN was_VBD associated_VBN with_IN a_DT relative_JJ risk_NN of_IN
          0_CD ._. 13_CD (_( 95_CD %_NN confidence_NN interval_NN 0_CD ._. 04_CD -_: 0_CD ._. 43_CD ;_: 
          P_NN <_NN 0_CD ._. 001_CD )_) for_IN severe_JJ QTc_NNP
          prolongation_NN ,_, while_IN female_JJ sex_NN was_VBD associated_VBN with_IN a_DT
          relative_JJ risk_NN of_IN 3_CD ._. 69_CD (_( 95_CD %_NN confidence_NN interval_NN
          1_CD ._. 27_CD -_: 10_CD ._. 73_CD ;_: 
          P_NN <_NN 0_CD ._. 02_CD )_) as_IN compared_VBN with_IN male_JJ
          sex_NN ._. A_DT second_JJ analysis_NN (_( analysis_NN 2_CD ,_, Table_NNP 2_LS )_) revealed_VBD
          that_DT hypokalemia_NN was_VBD associated_VBN with_IN a_DT relative_JJ risk_NN of_IN
          4_CD ._. 53_CD (_( 95_CD %_NN confidence_NN interval_NN 1_CD ._. 79_CD -_: 11_CD ._. 50_CD ;_: 
          P_NN <_NN 0_CD ._. 002_CD )_) as_IN compared_VBN with_IN
          normokalemia_NN ,_, while_IN the_DT relative_JJ risk_NN with_IN female_JJ sex_NN was_VBD
          4_CD ._. 45_CD (_( 95_CD %_NN confidence_NN interval_NN 1_CD ._. 55_CD -_: 12_CD ._. 78_CD ;_: 
          P_NN <_NN 0_CD ._. 01_CD )_) as_IN compared_VBN with_IN male_JJ
          sex_NN ._.
        
        
          Correlation_NNP between_IN serum_NN potassium_NN level_NN and_CC
          corrected_VBN QT_NNP interval_NN
          There_EX was_VBD a_DT significant_JJ inverse_NN correlation_NN between_IN
          serum_NN potassium_NN level_NN and_CC QTc_NNP interval_NN (_( Pearson_NNP 's_POS
          correlation_NN coefficient_NN 
          r_LS =_SYM -_: 0_CD ._. 439_CD ,_, 
          P_NN <_NN 0_CD ._. 0001_CD ;_: Fig_NNP ._. 1_LS a_DT )_) among_IN all_DT
          SAH_NNP patients_NNS ._. Furthermore_RB ,_, we_PRP evaluated_VBD the_DT impact_NN of_IN sex_NN
          on_IN the_DT correlation_NN between_IN serum_NN potassium_NN levels_NNS and_CC QTc_NNP
          interval_NN ._. Among_IN female_JJ SAH_NNP patients_NNS ,_, there_EX was_VBD a_DT
          significant_JJ inverse_NN correlation_NN between_IN serum_NN potassium_NN
          levels_NNS and_CC QTc_NNP interval_NN (_( 
          r_LS =_SYM -_: 0_CD ._. 474_CD ,_, 
          P_NN <_NN 0_CD ._. 0001_CD ;_: Fig_NNP ._. 1_LS c_SYM )_) ._. On_IN the_DT
          other_JJ hand_NN ,_, there_EX was_VBD no_DT significant_JJ correlation_NN between_IN
          the_DT serum_NN potassium_NN levels_NNS and_CC QTc_NNP intervals_NNS (_( 
          r_LS =_SYM -_: 0_CD ._. 009_CD ;_: Fig_NNP ._. 1_LS b_SYM )_) among_IN male_JJ SAH_NNP
          patients_NNS ._.
        
      
      
        Discussion_NNP
        The_DT present_JJ findings_NNS suggest_VBP that_IN female_JJ sex_NN and_CC
        hypokalemia_NN are_VBP independent_JJ risk_NN factors_NNS for_IN severe_JJ QTc_NNP
        prolongation_NN in_IN patients_NNS with_IN SAH_NNP ._. Recent_JJ clinical_JJ
        observations_NNS and_CC experimental_JJ data_NNS indicate_VBP sex-specific_JJ
        differences_NNS in_IN various_JJ ECG_NNP abnormalities_NNS ._. Several_JJ 
        in_IN vitro_NN and_CC 
        in_IN vivo_NN experimental_JJ studies_NNS [_NN 12_CD 13_CD
        14_CD ]_NN have_VBP shown_VBN that_IN female_JJ sex_NN is_VBZ a_DT strong_JJ risk_NN factor_NN for_IN
        drug-induced_JJ long_JJ QT_NNP interval_NN and_CC cardiac_JJ arrhythmias_NNS ._. In_IN a_DT
        study_NN of_IN healthy_JJ young_JJ individuals_NNS ,_, Stramba-_NNP Badiale_NNP and_CC
        coworkers_NNS [_NN 15_CD ]_NN demonstrated_VBN that_IN females_NNS had_VBD a_DT longer_RBR QTc_NNP
        interval_NN than_IN did_VBD males_NNS ._. Furthermore_RB ,_, recent_JJ evidence_NN
        suggested_VBD that_IN women_NNS are_VBP more_RBR prone_JJ than_IN men_NNS to_TO develop_VB
        torsades_NNS de_JJ pointes_NNS during_IN administration_NN of_IN cardiovascular_JJ
        drugs_NNS that_WDT prolong_VB cardiac_JJ repolarization_NN [_NN 9_CD 16_CD ]_NN ._.
        However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT mechanism_NN responsible_JJ
        for_IN these_DT sex_NN related_VBD differences_NNS in_IN the_DT QTc_NNP interval_NN or_CC in_IN
        the_DT occurrence_NN of_IN torsades_NNS de_JJ pointes_NNS ._. Several_JJ studies_NNS have_VBP
        indicated_VBN that_IN sex_NN hormones_NNS play_VBP an_DT important_JJ role_NN in_IN these_DT
        sex_NN differences_NNS ._. Drici_NNP and_CC coworkers_NNS [_NN 17_CD ]_NN showed_VBD that_DT
        ovariectomy_NN resulted_VBD in_IN a_DT shorter_JJR QT_NNP interval_NN ,_, and_CC high_JJ
        doses_NNS of_IN sex_NN hormones_NNS lengthened_VBD the_DT QT_NNP interval_NN ._. In_IN
        addition_NN ,_, Haseroth_NNP and_CC coworkers_NNS [_NN 18_CD ]_NN demonstrated_VBN that_DT
        estrogen_NN replacement_NN therapy_NN significantly_RB prolonged_JJ QTc_NNP
        intervals_NNS in_IN post-menopausal_JJ women_NNS ._. However_RB ,_, several_JJ other_JJ
        studies_NNS reported_VBD that_IN sex_NN hormones_NNS did_VBD not_RB affect_VB the_DT QT_NNP
        interval_NN in_IN healthy_JJ women_NNS [_NN 19_CD 20_CD ]_NN ._. Various_JJ factors_NNS may_MD
        be_VB involved_VBN in_IN the_DT sex-specific_JJ difference_NN in_IN ventricular_NN
        repolarization_NN (_( e_SYM ._. g_SYM ._. sex-related_JJ differences_NNS in_IN cardiac_JJ
        ionic_JJ channels_NNS )_) ._. Female_NNP rabbit_NN ventricular_NN myocytes_NNS had_VBD a_DT
        significantly_RB slower_RBR rapid_JJ component_NN of_IN the_DT delayed_VBN
        rectifier_NN than_IN did_VBD male_JJ cells_NNS ,_, which_WDT might_MD contribute_VB to_TO
        the_DT gender_NN difference_NN in_IN the_DT QT_NNP interval_NN [_NN 12_CD ]_NN ._. In_IN fact_NN ,_,
        most_JJS drugs_NNS that_WDT prolong_VB the_DT QTc_NNP interval_NN have_VBP been_VBN shown_VBN to_TO
        block_VB cardiac_JJ potassium_NN channels_NNS ,_, especially_RB the_DT rapid_JJ
        component_NN of_IN the_DT delayed_VBN rectifier_NN [_NN 21_CD 22_CD ]_NN ._.
        Women_NNP are_VBP more_RBR susceptible_JJ to_TO hypokalemia_NN ,_, especially_RB
        that_IN due_JJ to_TO diuretics_NNS [_NN 23_CD 24_CD ]_NN or_CC SAH_NNP [_NN 3_CD ]_NN ._. Considering_VBG
        that_IN hypokalemia_NN causes_VBZ a_DT prolongation_NN in_IN the_DT QTc_NNP interval_NN
        [_NN 4_CD 7_CD 8_CD 9_CD 25_CD ]_NN ,_, the_DT sex-specific_JJ difference_NN in_IN ventricular_NN
        repolarization_NN described_VBD above_IN might_MD result_VB from_IN the_DT
        sex-related_JJ difference_NN in_IN serum_NN potassium_NN levels_NNS ._. It_PRP is_VBZ
        interesting_JJ that_DT serum_NN potassium_NN levels_NNS did_VBD not_RB affect_VB QTc_NNP
        interval_NN among_IN male_JJ SAH_NNP patients_NNS ,_, whereas_IN there_EX was_VBD a_DT
        significant_JJ inverse_NN correlation_NN between_IN serum_NN potassium_NN
        levels_NNS and_CC QTc_NNP interval_NN among_IN female_JJ patients_NNS in_IN the_DT
        present_JJ study_NN ._.
        One_CD mechanism_NN that_WDT may_MD account_VB for_IN this_DT sex-specific_JJ
        difference_NN in_IN serum_NN potassium_NN levels_NNS is_VBZ a_DT sex-specific_JJ
        difference_NN in_IN the_DT activity_NN of_IN the_DT Na_NNP +_NN /_NN K_NNP +_NN -_: ATPase_NNP (_( Na_NNP +_NN /_NN K_NNP
        +_NN pump_NN )_) ,_, as_IN reported_VBN by_IN Lasker_NNP and_CC coworkers_NNS [_NN 26_CD ]_NN ._. Those_DT
        investigators_NNS found_VBD that_IN Na_NNP +_NN /_NN K_NNP +_NN -_: ATPase_NNP activity_NN in_IN red_JJ
        blood_NN cells_NNS was_VBD higher_JJR in_IN females_NNS than_IN in_IN males_NNS ,_, thus_RB
        leading_VBG to_TO a_DT sex-specific_JJ difference_NN in_IN the_DT Na_NNP +_NN /_NN K_NNP +_NN balance_NN
        in_IN both_DT the_DT intracellular_NN and_CC extracellular_NN spaces_NNS ._. Another_DT
        possible_JJ explanation_NN is_VBZ a_DT difference_NN in_IN the_DT total_JJ
        exchangeable_JJ body_NN potassium_NN ._. Kleinfeld_NNP and_CC coworkers_NNS [_NN 27_CD ]_NN
        demonstrated_VBN that_IN elderly_JJ women_NNS were_VBD more_RBR vulnerable_JJ to_TO
        hypokalemia_NN ,_, and_CC indicated_VBD that_IN this_DT was_VBD possibly_RB due_JJ to_TO
        age-_NN and_CC sex-associated_JJ differences_NNS in_IN body_NN mass_NN
        composition_NN ,_, which_WDT might_MD result_VB in_IN a_DT physiologically_RB low_JJ
        total_JJ exchangeable_JJ body_NN potassium_NN ._.
        An_DT inverse_NN correlation_NN between_IN the_DT serum_NN catecholamines_NNS
        and_CC potassium_NN levels_NNS suggests_VBZ that_IN a_DT catecholamine_NN surge_NN
        following_VBG SAH_NNP plays_VBZ an_DT important_JJ role_NN in_IN the_DT pathogenesis_NNS
        of_IN hypokalemia_NN during_IN the_DT acute_JJ phase_NN of_IN SAH_NNP ._. Recent_JJ
        evidence_NN suggested_VBD that_IN adrenaline-induced_JJ hypokalemia_NN
        resulted_VBD from_IN stimulation_NN of_IN a_DT β-adrenoceptor_JJ linked_VBN to_TO
        membrane_NN Na_NNP +_NN /_NN K_NNP +_NN -_: ATPase_NNP ,_, causing_VBG potassium_NN influx_NN [_NN 5_CD 28_CD ]_NN
        ._. On_IN the_DT other_JJ hand_NN ,_, there_EX was_VBD no_DT correlation_NN between_IN serum_NN
        cate-cholamine_JJ level_NN and_CC QTc_NNP interval_NN in_IN the_DT present_JJ
        series_NN ._. These_DT findings_NNS indicate_VBP that_IN a_DT catecholamine_NN surge_NN
        following_VBG SAH_NNP does_VBZ not_RB play_VB a_DT direct_JJ role_NN in_IN the_DT
        pathogenesis_NNS of_IN the_DT QTc_NNP prolongation_NN in_IN patients_NNS with_IN SAH_NNP ._.
        Interestingly_RB ,_, Reid_NNP and_CC coworkers_NNS [_NN 28_CD ]_NN showed_VBD that_DT serum_NN
        infused-adrenaline_JJ caused_VBN not_RB only_RB hypokalemia_NN but_CC also_RB a_DT
        prolongation_NN in_IN the_DT QTc_NNP interval_NN in_IN normal_JJ volunteers_NNS ,_,
        which_WDT appears_VBZ to_TO be_VB highly_RB consistent_JJ with_IN the_DT present_JJ
        findings_NNS in_IN patients_NNS with_IN SAH_NNP ._.
        The_DT therapeutic_JJ implications_NNS of_IN the_DT present_JJ findings_NNS are_VBP
        clear_JJ ._. When_WRB a_DT patient_NN with_IN SAH_NNP is_VBZ hospitalized_VBN during_IN the_DT
        acute_JJ phase_NN of_IN SAH_NNP ,_, as_IN a_DT rule_NN potassium-free_JJ intravenous_JJ
        fluids_NNS should_MD not_RB be_VB used_VBN as_IN initial_JJ fluid_JJ therapy_NN ,_,
        particularly_RB in_IN female_JJ patients_NNS ._. Furthermore_RB ,_, careful_JJ ECG_NNP
        monitoring_VBG is_VBZ needed_VBN to_TO detect_VB critical_JJ cardiac_JJ arrhythmias_NNS
        as_RB soon_RB as_IN possible_JJ ,_, and_CC avoidance_NN of_IN drugs_NNS that_WDT prolong_VB
        ventricular_NN repolarization_NN (_( quinidine_NN ,_, procainamide_NN ,_, and_CC
        disopyramide_NN )_) in_IN patients_NNS with_IN SAH_NNP ,_, especially_RB female_JJ
        patients_NNS ,_, is_VBZ mandatory_JJ ._. The_DT findings_NNS reported_VBD here_RB also_RB
        suggest_VBP an_DT important_JJ new_JJ direction_NN for_IN further_JJ research_NN ,_,
        focusing_VBG on_IN the_DT detection_NN of_IN critical_JJ cardiac_JJ arrhythmias_NNS
        in_IN order_NN to_TO prevent_VB sudden_JJ death_NN at_IN an_DT early_JJ stage_NN in_IN
        SAH_NNP ._.
        There_EX are_VBP some_DT limits_NNS to_TO the_DT conclusions_NNS that_WDT can_MD be_VB
        drawn_VBN from_IN the_DT present_JJ study_NN ._. The_DT study_NN lacks_VBZ data_NNS on_IN ECG_NNP
        changes_NNS after_IN admission_NN in_IN the_DT SAH_NNP patients_NNS ,_, which_WDT can_MD only_RB
        be_VB assessed_VBN by_IN means_NNS of_IN continuous_JJ Holter_NNP monitoring_VBG ._. It_PRP
        was_VBD therefore_RB impossible_JJ to_TO consider_VB the_DT influence_NN of_IN QTc_NNP
        prolongation_NN on_IN the_DT occurrence_NN of_IN critical_JJ cardiac_JJ
        arrhythmias_NNS such_JJ as_IN torsades_NNS de_JJ pointes_NNS ._. Further_RB studies_VBZ
        are_VBP required_VBN to_TO investigate_VB the_DT pathophysiologic_JJ basis_NN for_IN
        the_DT QTc_NNP prolongation_NN and_CC to_TO assess_VB ECG_NNP changes_NNS after_IN
        admission_NN in_IN patients_NNS with_IN SAH_NNP ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Key_JJ messages_NNS
        •_NN A_DT prolongation_NN in_IN QTc_NNP interval_NN is_VBZ often_RB observed_VBN
        during_IN the_DT acute_JJ phase_NN of_IN SAH_NNP
        •_NN Female_NNP sex_NN and_CC hypokalemia_NN are_VBP independent_JJ risk_NN
        factors_NNS for_IN severe_JJ QTc_NNP prolongation_NN in_IN patients_NNS with_IN
        SAH_NNP
        •_NN The_DT clinical_JJ implication_NN of_IN this_DT is_VBZ that_IN ,_, when_WRB a_DT
        patient_NN with_IN SAH_NNP is_VBZ hospitalized_VBN during_IN the_DT acute_JJ phase_NN of_IN
        SAH_NNP ,_, as_IN a_DT rule_NN potassium-free_JJ intravenous_JJ fluids_NNS should_MD not_RB
        be_VB used_VBN for_IN initial_JJ fluid_JJ therapy_NN ,_, particularly_RB in_IN female_JJ
        patients_NNS
        •_NN In_IN patients_NNS with_IN SAH_NNP ,_, careful_JJ ECG_NNP monitoring_VBG is_VBZ needed_VBN
        to_TO detect_VB critical_JJ cardiac_JJ arrhythmias_NNS as_RB soon_RB as_IN possible_JJ ,_,
        and_CC avoidance_NN of_IN drugs_NNS that_WDT prolong_VB ventricular_NN
        repolarization_NN (_( quinidine_NN ,_, procainamide_NN ,_, and_CC disopyramide_NN )_)
        is_VBZ mandatory_JJ ,_, especially_RB in_IN female_JJ SAH_NNP patients_NNS
      
      
        Abbreviations_NNP
        ECG_NNP =_SYM electrocardiogram_NN /_NN electrocardiography_NN ;_: Na_NNP +_NN /_NN K_NNP
        +_NN -_: ATPase_NNP =_SYM sodium_NN /_NN potassium_NN ATPase_NNP ;_: QTc_NNP =_SYM corrected_VBN QT_NNP ;_: SAH_NNP
        =_SYM subarachnoid_NN hemorrhage_NN ._.
      
    
  
